High-Dose IV Ketamine Infusion for Combat-Related PTSD in Veterans: Prospective Observational Case Series (Ross 2019, Ann Clin Psychiatry)
Prospective observational case series (Ann Clin Psychiatry 2019; Ross C, Jain R, Bonnett CJ, Wolfson P; PMID 31675388). Participants: 30 US military combat veterans (ages 18–75) with clinician-diagnosed combat-related PTSD. No control arm, no randomisation. Intervention: six 1-hour IV ketamine infusions over 2–3 weeks; first infusion at 1 mg/kg (max 60 mg), subsequent doses individually titrated to "psychotropic therapeutic response" (PTR). Outcomes: PCL-5 (PTSD) and PHQ-9 (depression) assessed pre-first and pre-sixth infusion. IRB-approved; written consent obtained. Design is explicitly described by authors as "observational case series". CT.gov: 0 hits; PubMed DataBankList empty.
Study Arms & Interventions
Ketamine infusion
experimentalA standard induction series of six 1-hour ketamine infusions, with doses adjusted to achieve a psychotropic therapeutic response (PTR).
Interventions
- Ketamine1.94 mg/kgvia IV• six 1-hour infusions over a 2-to 3-week period• 6 doses total
First infusion began at 1 mg/kg (max 60 mg); subsequent doses were adjusted based on patient response to achieve PTR. Mean dose was 1.94 mg/kg.
Primary Results(1 publication)
Participants
Adverse Events (from all publications)
| Arm / Group | n | Any TEAE | Severe | Serious | Discont. |
|---|---|---|---|---|---|
| Ketamine infusionexperimental | 30 | — | — | 0(0.0%) | — |
* The paper states 'none of the participants experienced any significant adverse events or significant vital sign abnormalities,' though it notes 'some occasional nausea'.
Study Details
- StatusCompleted
- Typeinterventional
- DesignNon-randomized
- Target Enrollment30 participants
- TimelineStart: 2017-01-01End: 2019-01-01
- Compound